Article
β2-Adrenoreceptor is a regulator of the α-synuclein gene driving risk of Parkinson’s disease
31 Aug 2017
Abstract excerpt
Elucidating the risk of Parkinson's disease High expression of the α-synuclein gene ( SNCA ) is a risk factor for Parkinson's disease (PD), but certain drugs may mitigate this risk. Mittal et al. ran a small-molecule screen to identify compounds that regulate levels of SNCA expression and found that several β2-adrenoreceptor (β2AR) agonists reduced them (see the Perspective by Snyder). These compounds modulated...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
